Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bad Homburg
Clinical trial register · Germany

Clinical Trials in Bad Homburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5081 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:18 UTC
5081
Studies in scope
all four open statuses
2880
Recruiting now
open to new participants
985
Lead sponsors
across recruiting studies
Top sites
Berlin 1591 Hamburg 896 Essen 767 Dresden 717 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 Eli Lilly and Company6 Amgen3 Boehringer Ingelheim3 Seaport Therapeutics2 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 Sanofi2 Zenas BioPharma (USA), LLC2 Philipps University Marburg1 University Medicine Greifswald1 Bristol-Myers Squibb1 Janssen Research & Development, LLC1 Gilead Sciences1 NewAmsterdam Pharma1 AGO Study Group1 Bielefeld University1 Alnylam Pharmaceuticals1 Nikolaj Frost MD1 Novartis Pharmaceuticals1 Ipsen1 Mirati Therapeutics Inc.1 Jena University Hospital1 Pfizer1 Tesaro, Inc.1 Hoffmann-La Roche1 Show all 30
Site location
Berlin1591 Hamburg896 Essen767 Dresden717 Heidelberg626 Cologne619 Leipzig515 München513 Hanover488 Tübingen457 Bonn424 Düsseldorf409 Munich398 Freiburg im Breisgau392 Erlangen373 Frankfurt369 Münster359 Frankfurt am Main346 Ulm343 Mainz336 Würzburg299 Aachen267 Augsburg248 Kiel236 Lübeck225 Show all 642
All 642 locations
Target enrolment
to

Trials with a site in Bad Homburg

50 of 5081 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Boehringer Ingelheim
Phase 3
600
Bad Homburg, Erlangen, Freiburg im Breisgau, Leipzig, Mainz
2026-11-18
Recruiting
Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer
NCT07816666Platinum-sensitive Relapsed Epithelial Ovarian Cancer, Platinum-sensitive Relapsed Fallopian Tube Cancer, Platinum-sensitive Relapsed Primary Peritoneal Cancer
DrugsTorvutatug samrotecan·Bevacizumab
AstraZeneca
Phase 3
600
Bad Homburg, Bonn, Brandenburg, Dresden, Düsseldorf, Essen, Gütersloh, Halle
2026-09-24
Recruiting
Zenas BioPharma (USA), LLC
Phase 3
990
Bad Homburg
2026-03-23
Recruiting
Zenas BioPharma (USA), LLC
Phase 3
705
Bad Homburg, Erbach im Odenwald
2026-03-23
Active, closed
Pfizer
Phase 3
3,578
Munich, Leipzig, Bad Homburg, Berlin, Dresden, Essen, Hamburg, Holstein
2025-12-19
Recruiting
Novartis Pharmaceuticals
Phase 2
165
Bad Homburg, Berlin, Hamburg
2025-10-28
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Aachen, Bad Homburg, Bayreuth, Bochum, Bremen, Erbach/Odenwald, Freiburg im Breisgau, Hamburg
2025-09-17
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Aachen, Ahaus, Altenburg, Bad Homburg, Berlin, Brandenburg an der Havel, Bremen, Cologne
2025-09-06
By invitation
Seaport Therapeutics
Phase 2
360
Berlin, Schwerin, Bad Homburg, Chemnitz
2025-09-02
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aachen, Bad Homburg, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Greifswald
2025-09-02
Recruiting
NSC-Therapeutics
Phase 1/2
90
Altenburg, Bad Homburg, Cologne, Göttingen, Mannheim, Ratingen
2025-08-25
Active, closed
Amgen
Phase 3
12,800
Bad Homburg, Bad Krozingen, Bad Oeynhausen, Berlin, Bochum, Bonn, Detmold, Dortmund
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Bad Homburg, Bad Krozingen, Bad Oeynhausen, Berlin, Bochum, Bremen, Bruchsal, Coburg
2025-07-22
Recruiting
Bristol-Myers Squibb
Phase 3
586
Munich, Göttingen, Bad Homburg, Chemnitz, Cologne, Ulm
2025-07-21
Recruiting
Sanofi
Observational
350
Auerbach, Augsburg, Bad Homburg, Berlin, Burgwedel, Darmstadt, Erkelenz, Flensburg
2025-07-01
Recruiting
AGO Research GmbH
Phase 2
42
Augsburg, Bad Homburg, Dresden, Düsseldorf, Essen, Göttingen, Hamburg, Hanau
2025-06-24
Recruiting
Seaport Therapeutics
Phase 2
360
Berlin, Schwerin, Bad Homburg, Chemnitz
2025-06-19
Recruiting
AstraZeneca
Phase 3
15,100
Amberg, Bad Bevensen, Bad Friedrichshall, Bad Homburg, Bad Oeynhausen, Bechhofen, Berlin, Bielefeld
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Amberg, Bad Homburg, Berlin, Dresden, Essen, Falkensee, Frankfurt, Freiburg im Breisgau
2025-05-28
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bad Friedrichshall, Bad Homburg, Bamberg, Berlin, Bonn, Bünde, Coburg, Dresden
2025-05-20
Active, closed
Eli Lilly and Company
Phase 3
487
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
487
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Active, closed
Eli Lilly and Company
Phase 3
974
Bad Homburg, Berlin, Cologne, Dresden, Essen, Leipzig, Oldenburg
2025-04-30
Recruiting
AstraZeneca
Phase 3
11,300
Aachen, Amberg, Bad Homburg, Bad Oeynhausen, Bamberg, Bechhofen, Berlin, Bochum
2025-03-14
Active, closed
Amgen
Phase 3
3,853
Aachen, Bad Homburg, Bad Krozingen, Bad Mergentheim, Bad Oeynhausen, Berlin, Dresden, Elsterwerda
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
Bad Homburg, Bamberg, Berlin, Bochum, Brandenburg an der Havel, Dresden, Essen, Friedrichsthal
2025-03-03
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Aachen, Ahaus, Alsfed, Bad Homburg, Berlin, Burg, Chemnitz, Detmold
2025-02-12
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bad Homburg, Böblingen, Dresden, Ebersberg, Essen, Hamburg, Heidelberg, Leipzig
2025-01-13
Active, closed
AbbVie
Observational
1,314
Heidelberg, Tübingen, Hoppegarten, Bad Homburg, Oldenburg, Greifswald, Siegen, Velbert
2024-11-26
Active, closed
Gilead Sciences
Phase 3
640
Bad Homburg, Düsseldorf, Essen, Hamburg, Hanover, Leipzig, München, Ulm
2024-08-28
Recruiting
AstraZeneca
Observational
300
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus
2024-07-25
Recruiting
Hannover Medical School
Not applicable
756
Ludwigsburg, Tübingen, Bad Homburg, Göttingen, Hanover, Lüneburg, Bielefeld, Düsseldorf
2024-07-17
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Bad Homburg, Berlin, Bochum, Essen, Giessen, Tübingen
2024-07-12
Recruiting
AstraZeneca
Observational
600
Bad Homburg, Berlin, Bremen, Celle, Chemnitz, Cologne, Deggendorf, Frankfurt
2024-06-28
Active, closed
Eli Lilly and Company
Phase 3
17,300
Aachen, Bad Friedrichshall, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2024-03-05
Recruiting
NeoRad Breast Cancer Study
NCT04261244Breast Cancer
Bielefeld University
Phase 3
1,826
Ahaus, Bad Homburg, Berlin, Bocholt, Dessau, Detmold, Düsseldorf, Georgsmarienhütte
2024-02-01
Active, closed
Nikolaj Frost MD
Phase 4
136
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Cologne, Dresden, Essen
2023-12-06
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Altenburg, Bad Friedrichshall, Bad Homburg, Bad Oeynhausen, Bamberg, Berlin, Beuel, Bielefeld
2023-04-11
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Aachen, Bad Homburg, Berlin, Günzburg, Homburg, Mannheim
2022-12-23
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bad Homburg, Bad Oeynhausen, Berlin, Dresden, Essen, Frankfurt, Freiburg im Breisgau, Hamburg
2022-10-11
Recruiting
AGO Study Group
Phase 3
970
Amberg, Augsburg, Bad Homburg, Berlin, Bielefeld, Brandenburg an der Havel, Bremen, Chemnitz
2022-09-13
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Bad Homburg, Berlin, Bremen, Chemnitz, Dortmund, Dresden, Elsterwerda, Erfurt
2022-02-07
Recruiting
ITP Registry and Accompanying Biospecimen Collection
NCT05152238Immune Thrombocytopenia
Jena University Hospital
Observational
1,100
Aachen, Altenburg, Aschaffenburg, Bad Homburg, Bad Liebenwerda, Berlin, Biberach, Bochum
2021-11-29
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Aachen, Amberg, Aue, Bad Elster, Bad Friedrichshall, Bad Homburg, Bad Krozingen, Bad Segeberg
2021-01-15
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Immenstadt im Allgäu, Amberg, Augsburg, Bad Homburg, Berlin, Braunschweig, Chemnitz, Cologne
2020-12-02
Active, closed
University Medicine Greifswald
Not applicable
130
Aachen, Allensbach, Bad Aibling, Bad Homburg, Bad Klosterlausnitz, Bad Sülze, Berlin, Gailingen
2019-12-06
Active, closed
Tesaro, Inc.
Phase 3
785
Amberg, Bad Homburg, Cologne, Dessau, Dresden, Essen, Frankfurt, Giessen
2019-07-18
Active, closed
AstraZeneca
Phase 3
1,407
Bad Homburg, Berlin, Bielefeld, Bonn, Brandenburg, Cologne, Dresden, Düsseldorf
2019-01-04
Active, closed
Ipsen
Observational
224
Aachen, Aschaffenburg, Augsburg, Bad Homburg, Bad Liebenwerda, Bad Schlema, Bamberg, Bergisch Gladbach
2018-09-24
Recruiting
Endometrial Cancer Lymphadenectomy Trial
NCT03438474Cancer of Endometrium Stage I, Cancer of Endometrium Stage II
Philipps University Marburg
Not applicable
640
Aalen, Amberg, Ansbach, Augsburg, Bad Homburg, Bamberg, Berlin, Bonn
2018-03-28
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-germany/city/bad-homburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,081 studies in total at the last sync on 13 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Bad Homburg.

How many clinical trials are recruiting in Bad Homburg?

24 of the 50 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 24 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bad Homburg), 50 studies
PhaseStudiesRecruitingShare
Phase 3321364%
Observational8416%
Phase 2438%
Not applicable326%
Phase 1/2112%
Phase 2/3112%
Phase 4102%

Most active sponsors

Lead sponsors with the most studies (Bad Homburg)
Lead sponsorStudiesRecruiting
AstraZeneca86
Eli Lilly and Company61
Amgen30
Boehringer Ingelheim32
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company20
Sanofi21
Seaport Therapeutics21
Zenas BioPharma (USA), LLC22
AbbVie10
AGO Research GmbH11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.